SMITHKLINE BEECHAM (EXPORT) LIMITED

Active London

Other business support service activities n.e.c.

0 employees website.com
Other business support service activities n.e.c.
S

SMITHKLINE BEECHAM (EXPORT) LIMITED

Other business support service activities n.e.c.

Founded 8 Oct 1993 Active London, United Kingdom 0 employees website.com
Other business support service activities n.e.c.

Previous Company Names

STERLING HEALTH (EXPORT) LIMITED 29 Dec 1993 — 2 Apr 1996
INTERCEDE 1058 LIMITED 8 Oct 1993 — 29 Dec 1993
Accounts Submitted 31 May 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 8 Sept 2025 Next due 22 Sept 2026 3 months remaining
Net assets £4M £224K 2024 year on year
Total assets £4M £296K 2024 year on year
Total Liabilities £166K £72K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Full company profile for SMITHKLINE BEECHAM (EXPORT) LIMITED (02860752), an active company based in London, United Kingdom. Incorporated 8 Oct 1993. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type audit-exemption-subsidiary
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£4.29M

Increased by £224.00k (+6%)

Total Liabilities

£166.00k

Increased by £72.00k (+77%)

Turnover

N/A

Employees

N/A

Debt Ratio

4%

Increased by 2 (+100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Michael Sean ReillyDirectorBritishUnited Kingdom5923 Jun 2023Active

Shareholders

Shareholders (1)

Smithkline Beecham Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GSK PLC united kingdom
SMITHKLINE BEECHAM (EXPORT) LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
31 May 2026AccountsAnnual accounts made up to 31 Dec 2025
31 May 2026AccountsAnnual accounts filed
31 May 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/12/25
31 May 2026OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/25
13 Nov 2025OfficersAppointment of Dr James Bringloe as director on 1 Nov 2025
31 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

31 May 2026 Accounts

Annual accounts filed

31 May 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/25

31 May 2026 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/25

13 Nov 2025 Officers

Appointment of Dr James Bringloe as director on 1 Nov 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

1 weeks ago on 31 May 2026

Annual accounts filed

1 weeks ago on 31 May 2026

Audit exemption statement of guarantee by parent company for period ending 31/12/25

1 weeks ago on 31 May 2026

Notice of agreement to exemption from audit of accounts for period ending 31/12/25

1 weeks ago on 31 May 2026

Appointment of Dr James Bringloe as director on 1 Nov 2025

6 months ago on 13 Nov 2025